Eric I. Richman - Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
GANX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eric I. Richman since 12 Mar 2025

Holdings reported by Eric I. Richman for Gain Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 289,629 $1,117,678 $3.86 01 Jul 2024 Direct
Common Stock 14,829 $57,225 $3.86 01 Jul 2024 By Trust
Stock Option (right to buy) 15,000 24 Jun 2025 Direct Common Stock

Transactions reported by Eric I. Richman for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.